Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

Low Risk

Score: 25/100

Failure Rate

0.0%

0 terminated/withdrawn out of 12 trials

Success Rate

100.0%

+13.5% vs industry average

Late-Stage Pipeline

0%

0 trials in Phase 3/4

Results Transparency

100%

12 of 12 completed trials have results

Key Signals

12 with results

Enrollment Performance

Analytics

N/A
12(100.0%)
12Total
N/A(12)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (12)